Leverage of nuclease-deficient CasX for preventing pathological angiogenesis
Haote Han(Zhejiang University), Hetian Lei(Massachusetts Eye and Ear Infirmary)
Cited by 6
Related Papers
Genome editing abrogates angiogenesis in vivo
|Nature Communications|2017|145
Expression of PDGFRα Is a Determinant of the PVR Potential of ARPE19 Cells
|Investigative Ophthalmology & Visual Science|2011|59
Chalcomoracin is a potent anticancer agent acting through triggering Oxidative stress via a mitophagy- and paraptosis-dependent mechanism
|Scientific Reports|2018|52
AAV-CRISPR/Cas9–Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro
|Investigative Ophthalmology & Visual Science|2017|40
A Novel Function of p53
|American Journal Of Pathology|2012|34